Patents by Inventor Michele Boisdron-Celle

Michele Boisdron-Celle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Individual 5-fluorouracile dose optimization in folfiri treatment
    Patent number: 9463193
    Abstract: The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5-FU dose administered by continuous infusion in patients treated by a FOLFIRI regimen or a similar regimen, based on the 5-FU plasmatic concentration measured during the previous 5-FU continuous infusion and on a herein described decision algorithm. The present invention also relates to a method for treating a cancer patient in which the 5-FU dose administered in continuous infusion in each FOLFIRI or similar treatment cycle is optimized using the decision algorithm according to the invention.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: October 11, 2016
    Assignees: INSTITUT DE CANCEROLOGIE DE L'OUEST, UNIVERSITE D'ANGERS
    Inventors: Erick Gamelin, Michéle Boisdron-Celle, Alain Morel
  • INDIVIDUAL 5-FLUOROURACILE DOSE OPTIMIZATION IN FOLFOX TREATMENT
    Publication number: 20110246079
    Abstract: The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5-FU dose administered by continuous infusion in patients treated by a FOLFOX regimen or a similar regimen, based on the 5-FU plasmatic concentration measured during the previous 5-FU continuous infusion and on a herein described decision algorithm. The present invention also relates to a method for treating a cancer patient in which the 5-FU dose administered in continuous infusion in each FOLFOX or similar treatment cycle is optimized using the decision algorithm according to the invention.
    Type: Application
    Filed: September 26, 2008
    Publication date: October 6, 2011
    Inventors: Erick Gamelin, Michèle Boisdron-Celle, Alain Morel
  • INDIVIDUAL 5-FLUOROURACILE DOSE OPTIMIZATION IN FOLFIRI TREATMENT
    Publication number: 20110177092
    Abstract: The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5-FU dose administered by continuous infusion in patients treated by a FOLFIRI regimen or a similar regimen, based on the 5-FU plasmatic concentration measured during the previous 5-FU continuous infusion and on a herein described decision algorithm. The present invention also relates to a method for treating a cancer patient in which the 5-FU dose administered in continuous infusion in each FOLFIRI or similar treatment cycle is optimized using the decision algorithm according to the invention.
    Type: Application
    Filed: September 26, 2008
    Publication date: July 21, 2011
    Inventors: Erick Gamelin, Michèle Boisdron-Celle, Alain Morel
  • Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium
    Publication number: 20050148661
    Abstract: The invention relates to products comprising calcium, injectable magnesium and an injectable product which releases oxalate during the metabolism thereof as a combination that can be used for simultaneous, sequential or separate administration in anticancer and antiviral therapies.
    Type: Application
    Filed: January 14, 2003
    Publication date: July 7, 2005
    Applicant: Centre Regional de Lutte Contre le Cancer
    Inventors: Laurence Gamelin, Erick Gamelin, Michele Boisdron-Celle, Alain Morel